The State of Cardiac Safety in Clinical Research - 2020 & Beyond

<p>What have you seen and experienced in cardiac safety in 2019?</p><p>Cardiac safety is typically seen as a very stable area. However, in 2019, there was a lot of evolution as sponsors began to look for ways to reduce patient burden and find <a href="https://www.ert.com/post-approval/">real-world cardiac evidence</a>. Enter wearables: advancements in these convenient devices have made it possible to track patients’ health and the safety and efficacy of therapies at home, as in <a href="https://clinicaltrials.gov/ct2/show/NCT03335800">Stanford Medicine’s Apple Heart Study.</a> This trend also reflects the shift toward home-based monitoring, which was reflected in the <a href="https://www.ert.com/blog/what-you-need-to-know-about-the-latest-abpm-fda-guidance/">FDA’s new guidance on ABPM</a>.</p><p>What do you anticipate happening in the industry in 2020 and beyond?</p><p>It’s become clear that passive health monitoring is the future of clinical trials. Technology will allow sponsors to c...